Results
7
Mid-Large Cap Stocks
7 companies
Novo Nordisk
Market Cap: DKK 1.9t
Engages in the research and development, manufacture, and distribution of pharmaceutical products in Europe, the Middle East, Africa, Mainland China, Hong Kong, Taiwan, North America, and internationally.
NOVO B
DKK 434.40
7D
1.3%
1Y
-52.4%
H. Lundbeck
Market Cap: DKK 32.4b
Engages in the research, development, manufacturing, and commercializing pharmaceuticals for the treatment of psychiatric and neurological disorders in Europe, United States, and internationally.
HLUN B
DKK 34.22
7D
14.2%
1Y
-8.1%
Genmab
Market Cap: DKK 80.3b
A biotechnology company, develops antibody-based products and product candidates for the treatment of cancer and other diseases in Denmark.
GMAB
DKK 1,295.00
7D
0.4%
1Y
-36.1%
Bavarian Nordic
Market Cap: DKK 12.5b
Develops, manufactures, and supplies life-saving vaccines.
BAVA
DKK 162.90
7D
5.0%
1Y
-6.0%
ALK-Abelló
Market Cap: DKK 36.9b
Operates as an allergy solutions company in Europe, North America, and internationally.
ALK B
DKK 166.70
7D
3.7%
1Y
6.9%
Zealand Pharma
Market Cap: DKK 28.8b
A biotechnology company, engages in the discovery, development, and commercialization of peptide-based medicines in Denmark and the United States.
ZEAL
DKK 400.50
7D
-2.7%
1Y
-35.2%
ChemoMetec
Market Cap: DKK 8.8b
Engages in the development, production, and sale of analytical equipment for cell counting and analysis the United States, Canada, Europe, and internationally.
CHEMM
DKK 498.20
7D
10.7%
1Y
35.4%